Get the Stockscreener App
4.56
1.56%
0.07
Goodrx Holdings Inc stock is traded at $4.56, with a volume of 4.46M.
It is up +1.56% in the last 24 hours and down -7.32% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$4.49
Open:
$4.49
24h Volume:
4.46M
Relative Volume:
1.80
Market Cap:
$449.53M
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-34.39
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
+22.25%
1M Performance:
-7.32%
6M Performance:
-5.20%
1Y Performance:
-39.68%
1-Day Range:
$4.4504
$4.7389
1-Week Range:
$4.281
$5.41
52-Week Range:
$3.305
$8.80
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.56 | 1.78B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Raymond James Downgrade Shakes GoodRx as Market Reacts - StocksToTrade
GoodRx Shares Slide Amid Profit-Taking After 30% Surge - AInvest
GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On? - inkl
GoodRx Stock Rises 29% Following Novo Nordisk Partnership - AInvest
GoodRx stock holds Neutral rating at Mizuho amid Novo Nordisk partnership - Investing.com
Mizuho Reiterates Neutral Rating on GoodRx Holdings Inc. (GDRX) - StreetInsider
Hims & Hers Health Stock Falls Amid Rival GoodRx's Deal with Novo Nordisk - AInvest
GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access - Benzinga
GoodRx Holdings Stock Price, Quotes and Forecasts | NASDAQ:GDRX - Benzinga
Top Stocks to Watch: Intel, Palo Alto Networks, Goodrx, Applied Digital, and Duolingo - AInvest
Intel, Palo Alto Networks, Goodrx, Applied Digital And Duolingo: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
GoodRx Earnings Call: Growth Amid Challenges - MSN
Is Novo Nordisk deal the much-needed catalyst for Goodrx stock? - TradingView
Why GoodRx (GDRX) Stock Is Trading Up Today - Yahoo Finance
GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning? (NASDAQ:GDRX) - Seeking Alpha
Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers - Reuters
GoodRx Is Soaring On A Novo Nordisk Deal. Should You Buy GDRX Stock Here? - Barchart.com
From Doubt To Action: Why I Bought Novo Nordisk After Earnings (NYSE:NVO) - Seeking Alpha
Soho House, GoodRx Holdings, Dayforce And Other Big Stocks Moving Higher On Monday - inkl
Meta's reported shake-up, Hims & Hers sinks on GoodRx–Novo deal - Yahoo Finance
GoodRx stock rating maintained at Underperform by BofA despite new offering - Investing.com
Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets - inkl
Stock Movers: Novo Nordisk, GoodRX, CVS - Bloomberg.com
GoodRx Holdings (GDRX) Stock: Shares Jump 35% on Novo Nordisk Partnership - parameter.io
BofA Securities Reiterates Underperform Rating on GoodRx Holdings Inc. (GDRX) - StreetInsider
GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month - Yahoo Finance
Why GoodRx Holds Promise Amidst Mixed Signals - StocksToTrade
Novo Nordisk partners with GoodRx for $499 monthly Ozempic, Wegovy (GDRX:NASDAQ) - Seeking Alpha
GoodRx Stock Soars 13.14% on Strategic Partnerships - AInvest
GoodRx partners with Novo Nordisk to offer Ozempic, Wegovy for $499 monthly - StreetInsider
$499 Monthly Ozempic Access: GoodRx and Novo Nordisk Launch Groundbreaking Affordability Program - Stock Titan
3 Promising Penny Stocks With Market Caps Under $2B - simplywall.st
Is it time to cut losses on GoodRx Holdings Inc.M&A Rumor & Pattern Based Trade Signal System - Newser
GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth - MSN
GoodRx Raises Guidance with Double-Digit Growth Driven by Pharma Partnerships - AInvest
Quant Strategy Flags GoodRx Holdings Inc. for Entry2025 Sector Review & Weekly High Potential Alerts - metal.it
GoodRx Holdings' (NASDAQ:GDRX) Performance Is Even Better Than Its Earnings Suggest - simplywall.st
Why Investors Shouldn't Be Surprised By GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 25% Share Price Plunge - 富途牛牛
GoodRx Holdings Inc. Stock Poised for Technical ComebackJuly 2025 Rallies & Community Verified Swing Trade Signals - thegnnews.com
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2025 Earnings Call Transcript - Insider Monkey
UBS Keeps Hold Rating on GoodRx Holdings with $4.25 Target - AInvest
GoodRx Q2 Earnings Miss Expectations Due to Rite Aid Bankruptcy and PBM Disruptions. - AInvest
GoodRx stock price target lowered to $4.25 from $5.25 at UBS - Investing.com Australia
GoodRx Holdings Inc. (GDRX) PT Lowered to $4.25 at UBS - StreetInsider
Deutsche Bank Adjusts GoodRx Price Target to $6 From $8, Maintains Hold Rating - MarketScreener
Raymond James Downgrades GoodRx Holdings to Outperform From Strong Buy, Adjusts Price Target to $5 From $9 - MarketScreener
GoodRx Holdings: Strategic Growth and Revised Projections Support Buy Rating Despite Short-term Adjustments - TipRanks
GoodRx Holdings: Buy Rating Maintained Despite Short-term Adjustments - AInvest
GoodRx Holdings Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and Elanco Animal Health (ELAN) - The Globe and Mail
GoodRx Holdings Inc. stock chart pattern explainedVolume Confirmed Setup with Entry Confidence - Newser
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Goodrx Holdings Inc Stock (GDRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Spectrum Equity VII, L.P. | 10% Owner |
Jul 03 '25 |
Sale |
4.80 |
10,677 |
51,226 |
0 |
1.72%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):